A total of 160 glaucoma patients and 160 healthy control subjects were enrolled. They had visited either the general health care clinic or the glaucoma clinic at Hanyang University Medical Center from September 2012 to January 2013. The institutional review board of Hanyang University Medical Center approved the study protocol and the tenets of the Declaration of Helsinki were followed. Informed consent was obtained from all participants before beginning the study.
All subjects underwent a comprehensive ophthalmic examination, including a visual acuity test, applanation tonometry, anterior segment examination, refraction, fundus examination, pachymetry (SP-3000; Tomey, Nagoya, Japan), standard automated perimetry (Humphrey Field analyzer with SITA standard 30-2 test; Carl Zeiss Meditec), and RNFL imaging with a spectral-domain OCT (Cirrus HD-OCT; Carl Zeiss Meditec).
Healthy subjects were included if they had a best-corrected visual acuity of 20/30 or better, a normal visual field, a normal anterior segment on slit-lamp examination, a normal-appearing optic disc head, no RNFL defects, and no history of IOP higher than 21 mm Hg. Glaucoma subjects were included based on the presence of RNFL defects on red-free photographs or the presence of the glaucomatous appearance of the optic nerve head on color fundus photographs (neuroretinal rim notching or thinning, or optic disc hemorrhage) and the presence of visual field defects that corresponded with RNFL defects and optic nerve head abnormalities. A visual field defect was defined as (1) the presence of a cluster of three or more nonedge contiguous points on a pattern deviation plot with a P value of less than 5% (one of which had a P value less than 1%) confirmed by at least two consecutive examinations, (2) a pattern standard deviation (PSD) with a P value less than 5%, or (3) a glaucoma hemifield test result outside normal limits. The severity of glaucomatous damage was classified as mild (mean deviation [MD] ≥ −6dB) or moderate-to-advanced (MD < −6dB). Visual field tests were considered reliable based on fixation losses and false-positive and false-negative results of 15% or less.
Eyes with high myopic or hyperopic refractive errors of less than −6.0 diopters or greater than +3.0 were excluded from this study. Eyes with any ophthalmic or neurologic disease known to affect RNFL thickness or visual function also were excluded.